Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Jan 29, 2020 10:52pm

116 Views

Post# 30617457

RE:RE:RE:RE:RE:RE:RE:Maybe those "insiders" knew something?

JohnF. i did say we have one signed contract in the last 10 years(not including Wanbang,which was 6 years ago and years away from fruition) that would be the R+F deal.
Quite sad considering the science. Lets hope we will see this change in 2020. I'am expecting it to change. I'm just not holding my breath.

Bullboard Posts

Two micro-cap stocks with strong fundamentals